Work-related musculoskeletal disorders: prevalence, ... Final Report European Agency for Safety and

  • View
    0

  • Download
    0

Embed Size (px)

Text of Work-related musculoskeletal disorders: prevalence, ... Final Report European Agency for Safety and

  • MSDs facts and figures overview: prevalence, costs and demographics of MSDs in Europe Final Report

    European Agency for Safety and Health at Work – EU-OSHA 1

    ISSN: 1831-9343

    Work-related musculoskeletal disorders: prevalence, costs and demographics in the EU European Risk Observatory

    Report

    European Agency for Safety and Health at Work

  • Work-related MSDs: prevalence, costs and demographics in the EU

    2

    European Agency for Safety and Health at Work – EU-OSHA

    Authors: Jan de Kok, Paul Vroonhof, Jacqueline Snijders, Georgios Roullis, Martin Clarke (Panteia), Kees Peereboom, Pim van Dorst ( vhp human performance), Iñigo Isusi (IKEI)

    Project management: Lorenzo Munar, Maurizio Curtarelli (EU-OSHA).

    This report was commissioned by the European Agency for Safety and Health at Work (EU-OSHA). Its contents, including any opinions and/or conclusions expressed, are those of the author(s) alone and do not necessarily reflect the views of EU-OSHA. This report is based on data from EU-OSHA (European Survey of Enterprises on New and Emerging Risks 2014 and 2019), Eurofound (European Working Conditions Survey 2005, 2010, 2015), Eurostat (Labour Force Survey ad hoc module 2013, European Health Interview Survey 2014, European Statistics on Accidents at Work 2016), and WHO (European Health for All database, European Mortality database). The responsibility for all conclusions drawn from these data lies entirely with the author(s).

    More information on the European Union is available on the Internet (http://europa.eu).

    Cataloguing data can be found on the cover of this publication.

    Luxembourg: Publications Office of the European Union, 2019

    ISBN: 978-92-9479-145-0

    doi:10.2802/66947

    © European Agency for Safety and Health at Work, 2019

    Reproduction is authorised provided the source is acknowledged.

    Europe Direct is a service to help you find answers to your questions about the European Union

    Freephone number (*):

    00 800 6 7 8 9 10 11

    (*) Certain mobile telephone operators do not allow access to 00 800 numbers, or these calls may be billed.

    http://europa.eu/

  • Work-related MSDs: prevalence, costs and demographics in the EU

    3

    European Agency for Safety and Health at Work – EU-OSHA

    Table of contents Executive summary .............................................................................................................................. 11

    Introduction ....................................................................................................................................... 11

    Policy context .................................................................................................................................... 11

    Main findings ..................................................................................................................................... 12

    Policy pointers ................................................................................................................................... 21

    Key messages .................................................................................................................................. 23 1 Introduction ................................................................................................................................ 25

    1.1 Background ................................................................................................................................ 25

    1.2 Objectives of the project ............................................................................................................ 25

    1.3 Methodology applied.................................................................................................................. 26

    1.4 Structure of the report ................................................................................................................ 26 2 Causes and consequences of MSDs: a framework .................................................................. 28

    2.1 Defining MSDs and assessing their prevalence ........................................................................ 28

    2.2 A multidimensional model of MSDs ........................................................................................... 33

    3 Prevalence of MSDs .................................................................................................................. 45

    3.1 Self-reported MSDs ................................................................................................................... 45

    3.2 Variation in self-reported MSD prevalence ................................................................................ 50 3.3 Administrative data on MSDs .................................................................................................... 69

    4 Impact of MSDs ......................................................................................................................... 79

    4.1 Health outcomes ........................................................................................................................ 79

    4.2 Employment and work outcomes .............................................................................................. 90

    5 Exposure to risk factors ............................................................................................................. 97

    5.1 Physical factors at work ............................................................................................................. 97 5.2 Organisational and psychosocial factors at work .................................................................... 116

    5.3 Workers’ opinions on the relationship between work and health ............................................ 141

    6 Prevention of MSDs ................................................................................................................. 145

    6.1 Prevention by establishments .................................................................................................. 145

    6.2 Impact of awareness on self-reported MSD prevalence ......................................................... 152

    7 Main results ............................................................................................................................. 154 7.1 Prevalence of MSDs ................................................................................................................ 154

    7.2 Impact of MSDs ....................................................................................................................... 157

    7.3 Exposure to risk factors ........................................................................................................... 159

    7.4 Preventive measures ............................................................................................................... 166

    8 Main conclusions and policy points ......................................................................................... 168 8.1 High prevalence of MSDs ........................................................................................................ 168

    8.2 Exposure to risk factors ........................................................................................................... 171

    8.3 Economic impact and social costs of MSDs ............................................................................ 174

  • Work-related MSDs: prevalence, costs and demographics in the EU

    4

    European Agency for Safety and Health at Work – EU-OSHA

    8.4 MSDs: a preventive approach ................................................................................................. 175

    8.5 The need to get a more complete data picture on MSDs ........................................................ 177

    8.6 MSDs are in need of targeted interventions ............................................................................ 177 8.7 Promoting musculoskeletal health among the working population in collaboration with other

    policy areas (public health sector, education sector, etc.) ....................................................... 177

    8.8 Improving data ......................................................................................................................... 178

    9 Annexes ................................................................................................................................... 180

    Annex 1 - Identification and analysis of relevant data sources .......................................................... 180

    Identification .................................................................................................................................... 180

    Analysis ........................................................................................................................................... 182 Annex 2 - Exploratory logistic regressions explaining MSD prevalence ............................................ 183

    Introduction ..................................................................................................................................... 183

    Methodology ................................................................................................................................... 183

    Results ...........................................